(RTTNews) - On Thursday, Recursion Pharmaceuticals (RXRX) priced an offering of 61.54 million Class A shares at $3.25 each, expecting to raise approximately $200 million before expenses.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。
Veytics Intelligence
Recursion Pharmaceuticals Prices Offering Of 61.54 Mln Shares At $3.25/Shr
